Literature DB >> 30610899

The age-related changes and differences in energy metabolism and glutamate-glutamine recycling in the d-gal-induced and naturally occurring senescent astrocytes in vitro.

Pei Cao1, Jingjing Zhang1, Yuyan Huang1, Yujia Fang1, Jianxin Lyu2, Yao Shen3.   

Abstract

Previously, we successfully established a d-galactose (d-gal)-induced astrocyte aging model in vitro. However, whether the changes in the aged astrocytes induced by d-gal are similar to those occurred in naturally are unknown. Therefore, in current study, we simultaneously established d-gal-induced and naturally aged astrocyte aging models in vitro to explore the age-related changes and to compare the differences in these two astrocyte aging models. The Seahorse Extracellular Flux Analyzer was used to examine the mitochondrial metabolism and glycolysis activities of the young and senescent astrocytes. The results showed that the mitochondrial ATP-linked oxygen consumption rates (OCRs) were decreased markedly both in the d-gal-induced and naturally occurring senescent astrocytes. The basal glycolysis activity was increased in the naturally occurring senescent astrocytes, whereas it was decreased in the d-gal-induced senescent astrocytes. Western blot analysis showed that isocitrate dehydrogenase 3 (IDH3), succinate dehydrogenase (SDH) and malate dehydrogenase 2 (MDH2) were markedly decreased both in these two aging models, whereas the ironsulfur cluster assembly enzyme (ISCU) was up-regulated in the naturally occurring senescent astrocytes but was down-regulated in the d-gal-induced senescent astrocytes. The expression levels of glial glutamate transporter-1 (GLT-1), glutamine synthetase (GS) and γ-aminobutyric acid type B receptor subunit 2 (GABABR2) were also markedly decreased in these two aging models. In addition, the PI3K/AKT signaling pathway was to be inactivated both in the d-gal-induced and naturally occurring senescent astrocytes. These results indicate that the age-related changes in d-gal-induced senescent astrocytes are not fully consistent with those in naturally occurring senescent astrocytes, and it may be not suitable to use d-gal-induced senescent astrocytes to replace the naturally occurring senescent astrocytes to explore the aging mechanisms under some circumstances.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Aging; Astrocyte; Glutamine synthetase; Glycolysis; Mitochondrial metabolism; PI3K/AKT signal pathway

Mesh:

Substances:

Year:  2019        PMID: 30610899     DOI: 10.1016/j.exger.2018.12.018

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  6 in total

1.  Aging related impairment of brain microvascular bioenergetics involves oxidative phosphorylation and glycolytic pathways.

Authors:  Siva Svp Sakamuri; Venkata N Sure; Lahari Kolli; Wesley R Evans; Jared A Sperling; Gregory J Bix; Xiaoying Wang; Dmitriy N Atochin; Walter L Murfee; Ricardo Mostany; Prasad Vg Katakam
Journal:  J Cereb Blood Flow Metab       Date:  2022-03-16       Impact factor: 6.960

2.  Effects of C5a and Receptor CD88 on Glutamate and N-Methyl-D-Aspartic Acid Receptor Expression in the Mouse Model of Optic Neuromyelitis.

Authors:  Ling Li; Jiangwei Tang; Hongxin Wang; Jiamei Liu; Lina Zhou
Journal:  Comput Math Methods Med       Date:  2022-04-25       Impact factor: 2.809

3.  Astragaloside IV inhibits astrocyte senescence: implication in Parkinson's disease.

Authors:  Mei-Ling Xia; Xia-Hong Xie; Jian-Hua Ding; Ren-Hong Du; Gang Hu
Journal:  J Neuroinflammation       Date:  2020-04-06       Impact factor: 8.322

Review 4.  Metabolic Features of Brain Function with Relevance to Clinical Features of Alzheimer and Parkinson Diseases.

Authors:  David Allan Butterfield; Maria Favia; Iolanda Spera; Annalisa Campanella; Martina Lanza; Alessandra Castegna
Journal:  Molecules       Date:  2022-01-30       Impact factor: 4.411

5.  Schisandrin alleviates the cognitive impairment in rats with Alzheimer's disease by altering the gut microbiota composition to modulate the levels of endogenous metabolites in the plasma, brain, and feces.

Authors:  Chengqin Zhang; Ying Zhang; Tiantian Zhao; Tingting Mou; Wang Jing; Jian Chen; Wenqian Hao; Shuo Gu; Meirong Cui; Yue Sun; Binbin Wei
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

Review 6.  Residual Disease in Glioma Recurrence: A Dangerous Liaison with Senescence.

Authors:  Diana A Putavet; Peter L J de Keizer
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.